IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

INTRODUCTION: Patients with atrial fibrillation frequently suffer from heart failure with preserved ejection fraction. At present there is no proven therapy to improve physical capacity and quality of life in participants with permanent atrial fibrillation with preserved left ventricular contractili...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: Shantsila, Eduard, Haynes, Ronnie, Calvert, Melanie, Fisher, James, Kirchhof, Paulus, Gill, Paramjit S, Lip, Gregory Y H
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2016
Témata:
Cardiovascular Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073497/
https://ncbi.nlm.nih.gov/pubmed/27707827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012241
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky